Vimarsana
Biggest News Aggregation in the World

Page 2 - Strides Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Strides Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Strides Pharma Today - Breaking & Trending Today

'Investing systematically in markets through SIPs, mutual funds, stocks': BJP's Tejasvi Surya on his investment formulae - Vimarsana News

'Investing systematically in markets through SIPs, mutual funds, stocks': BJP's Tejasvi Surya on his investment formulae

As per the affidavit filed with the Election Commission of India, Surya's main sources of income were investments in shares and mutual funds. He invested Rs 1.79 crore in shares and Rs 1.99 crore in mutual funds.

Strides Pharma gets USFDA nod for antidepressant medication - Vimarsana News

Strides Pharma gets USFDA nod for antidepressant medication

The company's Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food & Drug Administration (USFDA), the drug firm said in a regulatory filing.

Strides Pharma shares hit 52-week high despite 2 observations from USFDA - Vimarsana News

Strides Pharma shares hit 52-week high despite 2 observations from USFDA

Strides Pharma Share Price | It will respond to these observations comprehensively to FDA within the stipulated time, the pharmaceutical firm has said

Strides Pharma Hits 52-Week High Despite FDA Observations - Vimarsana News

Strides Pharma Hits 52-Week High Despite FDA Observations

The USFDA conducted a routine inspection of the formulations facility of Strides Alathur Private Limited, a wholly-owned subsidiary, in Chennai from April 1 to April 5.

BJP MP Tejasvi Surya's assets jump 30-fold in 5 years: Report - Vimarsana News

BJP MP Tejasvi Surya's assets jump 30-fold in 5 years: Report

The Bengaluru South MP’s assets jumped from Rs 13.46 lakh in 2019 to Rs 4.10 crore in 2024